VolitionRx Limited (VNRX) Shareholder Equity
- 2026-06-30: Common Stock, Value, IssuedUSD $12.04K; Additional Paid in CapitalUSD $235.26M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-88.45K; Retained Earnings (Accumulated Deficit)USD $-267.35M.
- 2026-03-31: Common Stock, Value, IssuedUSD $7.93K; Additional Paid in CapitalUSD $227.74M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-160.76K; Retained Earnings (Accumulated Deficit)USD $-259.57M.
- 2025-12-31: Common Stock, Value, IssuedUSD $6.29K; Additional Paid in CapitalUSD $218.94M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-295.07K; Retained Earnings (Accumulated Deficit)USD $-252.90M.
- 2025-09-30: Common Stock, Value, IssuedUSD $109.62K; Additional Paid in CapitalUSD $212.31M; Accumulated Other Comprehensive Income (Loss), Net of TaxUSD $-421.95K; Retained Earnings (Accumulated Deficit)USD $-246.63M.
VolitionRx Limited Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Stockholders' Equity, Including Portion Attributable to Noncontrolling Interest USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Adjustments to Additional Paid in Capital, Warrant Issued USD | APIC, Share-based Payment Arrangement, Recognition and Exercise USD | Additional Paid in Capital, Common Stock USD | Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax USD | Treasury Stock, Value, Acquired, Cost Method USD | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Option, Increase for Cost Recognition USD | Noncontrolling Interest in Variable Interest Entity USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $12.04K | $235.26M | $-88.45K | $-267.35M | $-32.16M | $-33.54M | 3 month · $238.00K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2026-03-31 | $7.93K | $227.74M | $-160.76K | $-259.57M | $-31.97M | $-33.36M | 3 month · $224.98K | 3 month · $615.85K | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $6.29K | $218.94M | $-295.07K | $-252.90M | $-34.25M | $-35.59M | 12 month · $1.64M | (m) | 12 month · $103.57K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $109.62K | $212.31M | $-421.95K | $-246.63M | $-34.64M | $-35.95M | 3 month · $609.17K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $103.98K | $209.78M | $-444.29K | $-241.25M | $-31.82M | $-33.10M | 3 month · $812.04K | 3 month · $2.00M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $100.75K | $206.96M | $131.70K | $-234.97M | $-27.77M | $-29.03M | 3 month · $347.80K | (m) | 3 month · $103.57K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $96.10K | $204.15M | $385.63K | $-229.54M | $-24.91M | $-26.11M | 12 month · $1.27M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $92.39K | $202.01M | $140.27K | $-223.75M | $-21.50M | $-22.64M | 3 month · $323.54K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $82.93K | $195.76M | $282.25K | $-217.93M | $-21.81M | $-22.90M | 3 month · $208.05K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $82.11K | $195.00M | $258.97K | $-210.94M | $-15.61M | $-16.62M | 3 month · $411.22K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-12-31 | $81.90K | $194.45M | $243.94K | $-202.58M | $-7.80M | $-8.71M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 12 month · $2.29M | (m) |
| 2023-09-30 | $78.34K | $191.52M | $239.62K | $-193.88M | $-2.04M | $-2.85M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | $78.14K | $191.07M | $208.33K | $-185.51M | $5.84M | $5.12M | (m) | (m) | 3 month · $592.17K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-03-31 | $63.11K | $173.47M | $170.62K | $-176.04M | $-2.34M | $-2.98M | (m) | (m) | 3 month · $693.66K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-12-31 | $57.87K | $164.40M | $227.10K | $-167.26M | $-2.57M | $-3.13M | (m) | (m) | 12 month · $3.11M | (m) | (m) | (m) | (m) | 12 month · $3.11M | (m) |
| 2022-09-30 | $57.50K | $162.94M | $315.55K | $-160.02M | $2.84M | $2.84M | (m) | (m) | 3 month · $639.08K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | $53.85K | $156.44M | $244.52K | $-152.27M | $4.08M | $4.08M | (m) | (m) | 3 month · $854.30K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-03-31 | $53.79K | $155.66M | $30.42K | $-144.62M | $10.81M | $10.81M | (m) | (m) | 3 month · $915.03K | (m) | (m) | (m) | (m) | (m) | $-306.27K |
| 2021-12-31 | $53.77K | $154.73M | $148.33K | $-136.99M | $17.72M | $17.72M | (m) | (m) | 12 month · $2.67M | (m) | (m) | (m) | (m) | (m) | $-222.29K |
| 2021-09-30 | $53.22K | $150.22M | $8.73K | $-128.95M | $21.18M | $21.33M | (m) | (m) | 3 month · $732.19K | (m) | (m) | (m) | (m) | (m) | $-149.21K |
| 2021-06-30 | $53.14K | $148.47M | $29.61K | $-121.82M | $26.63M | $26.63M | (m) | (m) | 3 month · $337.74K | (m) | (m) | (m) | (m) | (m) | $-104.14K |
| 2021-03-31 | $52.87K | $147.38M | $74.16K | $-116.29M | $31.16M | $31.16M | (m) | (m) | 3 month · $555.34K | (m) | (m) | 3 month · $0.00 | (m) | (m) | $-56.60K |
| 2020-12-31 | $48.61K | $126.53M | $-59.98K | $-110.17M | $16.29M | $16.29M | (m) | (m) | (m) | (m) | (m) | 12 month · $-54.43K | (m) | (m) | $-47.18K |
| 2020-09-30 | $48.06K | $124.12M | $-148.12K | $-105.04M | $18.96M | $18.98M | (m) | (m) | (m) | (m) | (m) | 9 month · $-54.43K | (m) | (m) | $-23.40K |
| 2020-06-30 | $46.66K | $118.92M | $425.28K | $-100.71M | $18.66M | $18.68M | (m) | (m) | (m) | (m) | (m) | 6 month · $-54.43K | (m) | (m) | $-15.35K |
| 2020-03-31 | $41.21K | $104.33M | $499.60K | $-95.68M | $9.19M | $9.19M | (m) | (m) | (m) | (m) | (m) | 3 month · $-54.43K | (m) | (m) | $-9.57K |
| 2019-12-31 | $41.12K | $103.85M | $125.67K | $-89.82M | $14.20M | $14.20M | (m) | (m) | (m) | (m) | (m) | 12 month · $0.00 | (m) | (m) | $0.00 |
| 2019-09-30 | $41.09K | $103.37M | $650.82K | $-86.26M | $17.80M | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $0.00 | 9 month · $2.00 | (m) | (m) |
| 2019-06-30 | $39.48K | $98.18M | $249.51K | $-82.08M | $16.38M | (m) | (m) | (m) | (m) | (m) | (m) | 6 month · $0.00 | (m) | (m) | (m) |
| 2019-03-31 | $37.81K | $92.80M | $199.60K | $-77.93M | $15.11M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-12-31 | $35.34K | $85.60M | $223.65K | $-73.72M | $12.14M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-09-30 | $35.03K | $84.44M | $64.11K | $-69.44M | $15.11M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | 9 month · $12.00 | (m) | (m) |
| 2018-06-30 | $30.03K | $74.96M | $17.76K | $-64.96M | $10.05M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2018-03-31 | $30.03K | $74.46M | $-114.40K | $-60.37M | $14.01M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-12-31 | $26.52K | $65.77M | $-129.34K | $-55.71M | $9.96M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2017-09-30 | $26.52K | (m) | $-132.88K | $-51.65M | $13.39M | (m) | (m) | (m) | (m) | $65.15M | (m) | (m) | (m) | (m) | (m) |
| 2017-06-30 | $26.47K | (m) | $-100.48K | $-47.76M | $16.58M | (m) | (m) | (m) | (m) | $64.42M | (m) | (m) | (m) | (m) | (m) |
| 2017-03-31 | $26.15K | (m) | $-161.79K | $-44.30M | $18.49M | (m) | (m) | (m) | (m) | $62.92M | (m) | (m) | (m) | (m) | (m) |
| 2016-12-31 | $26.13K | $62.29M | $-193.30K | $-40.94M | $21.18M | (m) | (m) | (m) | (m) | $62.29M | (m) | (m) | (m) | (m) | (m) |
| 2016-09-30 | $23.61K | (m) | $-117.75K | $-37.96M | $11.81M | (m) | (m) | (m) | (m) | $49.86M | (m) | (m) | (m) | (m) | (m) |
| 2016-06-30 | $23.52K | $48.93M | $-133.22K | $-34.48M | $14.33M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2016-03-31 | $23.40K | $48.48M | $-65.79K | $-31.53M | $16.91M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-12-31 | $18.76K | $35.15M | $-84.17K | $-29.04M | $6.04M | (m) | (m) | (m) | (m) | $35.15M | (m) | (m) | (m) | (m) | (m) |
| 2015-09-30 | $18.07K | $33.54M | $-65.25K | (m) | $7.14M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-06-30 | $18.04K | $32.87M | $-79.71K | (m) | $9.41M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2015-03-31 | $17.93K | $32.70M | $-124.97K | (m) | $11.08M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-12-31 | $14.69K | $19.97M | $-103.83K | (m) | $368.18K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-09-30 | $14.31K | $14.55M | $-93.53K | (m) | $-4.10M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-06-30 | $13.47K | $12.20M | $-73.63K | (m) | $-532.35K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2014-03-31 | $13.31K | $11.88M | $-63.99K | (m) | $-1.66M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-12-31 | $11.68K | $12.02M | $-59.80K | (m) | $680.67K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-09-30 | $11.19K | $10.90M | $-52.61K | (m) | $391.24K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-06-30 | $10.94K | $10.25M | $-46.13K | (m) | $678.59K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2013-03-31 | $10.44K | $9.08M | $-33.26K | (m) | $691.03K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-12-31 | $10.19K | $8.44M | $-34.28K | (m) | $833.79K | (m) | (m) | (m) | (m) | (m) | $34.28K | (m) | (m) | (m) | (m) |
| 2012-09-30 | $9.88K | $7.26M | $-41.02K | (m) | $1.12M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | $9.33K | $6.20M | $-34.62K | (m) | $1.21M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | $8.65K | $4.79M | $1.31K | (m) | $970.39K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | $8.65K | $4.58M | $4.64K | (m) | $1.09M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2010-12-31 | $4.14K | $668.34K | $-39.29K | (m) | $-230.93K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cardio Diagnostics Holdings, Inc. (CDIO) | United States | $0.006B | |
| Q/C TECHNOLOGIES, INC. (QCLS) | United States | $0.008B | -1.93 |
| BIOMERICA INC (BMRA) | United States | $0.011B | |
| IMMUCELL CORP /DE/ (ICCC) | United States | $0.091B | 116.10 |
| Insight Molecular Diagnostics Inc. (IMDX) | United States | $0.129B | -3.90 |
| MYRIAD GENETICS INC (MYGN) | United States | $0.397B | -4.84 |
| Alpha Teknova, Inc. (TKNO) | United States | $0.500B | -18.12 |
| QuidelOrtho Corp (QDEL) | United States | $0.733B | -0.90 |
| ACHIEVE LIFE SCIENCES, INC. (ACHV) | United States | $0.806B | -5.88 |
| Intellia Therapeutics, Inc. (NTLA) | United States | $1.705B | -5.92 |